Portfolio company
EverZom
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops exosome-based regenerative therapies and a biomanufacturing platform for pharmaceutical laboratories, biotechnology firms, and cosmetics companies.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Exostemtech
This biotechnology firm develops exosome-based therapeutics and production platforms for clinical researchers and healthcare providers treating intractable diseases.
Spot Biosystems
This company develops non-viral gene therapy delivery platforms using extracellular vesicles to treat genetic diseases for pharmaceutical partners and healthcare providers.
Esphera SynBio
This synthetic biology company develops engineered exosome therapies to deliver therapeutic payloads for cancer and infectious disease treatments within the biopharmaceutical sector.
Everna
This biotechnology company develops stem cell models and therapeutic drugs to treat age-related neurodegenerative and cardiovascular diseases for the medical industry.
EsoBiotec
The company develops off-the-shelf in vivo cell therapies to treat cancer and autoimmune diseases for patients and pharmaceutical partners.
Hermes Biosciences
This company develops automated benchtop systems for isolating extracellular vesicles from biological samples for clinical researchers, pharmaceutical companies and academic institutions.
Evox Therapeutics
This biotechnology company develops engineered exosome therapeutics to deliver genetic medicines and proteins for patients with rare diseases and neurological disorders.
Nexosome Oncology
The company develops exosome-based blood tests for early-stage cancer detection and provides biomarker discovery services for pharmaceutical and biotechnology organisations.
